Scientific Sessions 2024  /  Featured Science: Novel Approaches to Managing Lipid Risk  /  Discussant: YELLOW III
Logo

American Heart Association

  2
  0

Final ID:

Discussant: YELLOW III

  • Mora, Samia  ( BRIGHAM AND WOMENS HOSPITAL , Boston , Massachusetts , United States )
  • Kramer, Christopher  ( Univ. of Virginia Health System , Charlottesville , Virginia , United States )
    • Author Disclosures:
    Samia Mora: DO have relevant financial relationships ; Royalties/Patent Beneficiary:co-inventor on patent application on glycosylation and cardiovascular disease issued to Genos and Brigham and Women's Hospital:Active (exists now) | Christopher Kramer: DO have relevant financial relationships ; Research Funding (PI or named investigator):BMS:Active (exists now) ; Research Funding (PI or named investigator):Cytokinetics:Active (exists now)
Meeting Info:

Scientific Sessions 2024

2024

Chicago, Illinois

Session Info:

Featured Science: Novel Approaches to Managing Lipid Risk

Saturday, 11/16/2024 , 01:30PM - 02:45PM

Featured Science

More abstracts on this topic:
Efficacy and Safety of Lerodalcibep, a Third Generation PCSK9 Inhibitor, in 703 Heterozygous Familial Hypercholesterolemia Subjects in the Open Label Extension Trial

Raal Frederick, Fourie Nyda, Scott Russell, Blom Dirk, Kayikcioglu Meral, Vest Jeff, Kallend David, Stein Evan

Discussant: PALISADE

Shapiro Michael

More abstracts from these authors:
What a New CV Board Might Mean for Me?

Kramer Christopher, Fry Edward

Effect of Tirzepatide on Cardiac Structure and Function in Obese HFpEF: the SUMMIT CMR Substudy

Kramer Christopher

You have to be authorized to contact abstract author. Please, Login
Not Available